El-Battrawy I
235  Ergebnisse:
Personensuche X
?
1

The use of wearable cardioverter defibrillator among patien..:

El-Battrawy, I ; Koepsel, K ; Kovacs, B...
European Heart Journal.  44 (2023)  Supplement_2 - p. , 2023
 
?
2

Wearable cardioverter defibrillator after ICD-system explan..:

El-Battrawy, I ; Beiert, T ; Koepsel, K...
European Heart Journal.  44 (2023)  Supplement_2 - p. , 2023
 
?
4

Antiplatelet therapy and outcome in patients with COVID-19...:

Santoro, F ; Vitale, E ; Nunez Gil, I...
European Heart Journal.  42 (2021)  Supplement_1 - p. , 2021
 
?
5

Metabolic treatment of an electrical disease? Beneficial AP..:

Hornyik, T ; Bodi, I ; Michaelides, K...
European Heart Journal.  42 (2021)  Supplement_1 - p. , 2021
 
?
 
?
8

Cardiac contractility modulation efficacy: is there a diffe..:

Fastner, C ; Akin, I ; Yuecel, G...
European Heart Journal.  41 (2020)  Supplement_2 - p. , 2020
 
?
9

Gen-editing to model Short QT syndrome type 5 using human-i..:

El-Battrawy, I ; Maywald, L ; Cyganek, L...
European Heart Journal.  41 (2020)  Supplement_2 - p. , 2020
 
?
 
?
11

Gender-based comparison of takotsubo syndrome versus myocar..:

Giannakopoulos, K ; El-Battrawy, I ; Gietzen, T...
QJM: An International Journal of Medicine.  112 (2019)  5 - p. 355-362 , 2019
 
?
12

1206Doxapram is a promising new antiarrhythmic drug for an ..:

Schmidt, C ; Wiedmann, F ; Beyersdorf, C...
European Heart Journal.  40 (2019)  Supplement_1 - p. , 2019
 
?
 
?
 
1-15